A case of novel DYT6 dystonia variant with serious complications after deep brain stimulation therapy: a case report

Background DYT6 dystonia belongs to a group of isolated, genetically determined, generalized dystonia associated with mutations in the THAP1 gene. Case presentation We present the case of a young patient with DYT6 dystonia associated with a newly discovered c14G>A (p.Cys5Tyr) mutation in the THAP1 gene. We describe the clinical phenotype of this new mutation, effect of pallidal deep brain stimulation (DBS), which was accompanied by two rare postimplantation complications: an early intracerebral hemorrhage and delayed epileptic seizures. Among the published case reports of patients with DYT6 dystonia, the mentioned complications have not been described so far. Conclusions DBS in the case of DYT6 dystonia is a challenge to thoroughly consider possible therapeutic benefits and potential risks associated with surgery. Genetic heterogeneity of the disease may also play an important role in predicting the development of the clinical phenotype as well as the effect of treatment including DBS. Therefore, it is beneficial to analyze the genetic and clinical relationships of DYT6 dystonia.

Automated summary

This article presents a case of DYT6 dystonia associated with a newly discovered mutation in the THAP1 gene. The patient experienced complications, including early intracerebral hemorrhage and delayed epileptic seizures, during the deep brain stimulation (DBS) treatment. The study highlights the importance of carefully considering the therapeutic benefits and potential risks of DBS for DYT6 dystonia.